Doctor profile · Federal record

Dr. Diana Superfin, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Walnut Creek, CA

  • NPI 1750365953
  • Accepts Medicare
  • MIPS 0.0 / 100 · 2023
  • 24 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
500 Lennon Ln
Walnut Creek, CA 945982415
(925) 939-9610

Credentials & registration

NPPES · NUCC
NPI registered
December 2005 — 21 yrs on file
Profile last updated
September 23, 2009
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #A84532

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1750365953. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
103,032
Distinct HCPCS
10
Medicare allowed
$1,220,045
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 34,500 24 $1
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 16,830 18 $1
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 16,600 17 $3
J1453 Injection, fosaprepitant, 1 mg 12,750 22 $0
J0897 Injection, denosumab, 1 mg 7,020 52 $23
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,200 33 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,734 39 $0
J2469 Injection, palonosetron hcl, 25 mcg 1,450 30 $1
99215 Established patient office or other outpatient visit, 40-54 minutes 1,092 321 $214
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg 972 25 $112

In context: peer comparison

Among 6 peers in this city , average services per provider: 1,407. This provider delivers 73× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$7,536
Transactions
174
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 16 $3,104.08
PFIZER INC. 40 $709.75
Novartis Pharmaceuticals Corporation 13 $277.80
GlaxoSmithKline, LLC. 12 $255.98
Daiichi Sankyo Inc. 13 $227.93
E.R. Squibb & Sons, L.L.C. 17 $227.85
Celgene Corporation 16 $226.07
Janssen Biotech, Inc. 8 $222.08
Merck Sharp & Dohme LLC 9 $205.90
ABBVIE INC. 7 $158.28
Lilly USA, LLC 5 $127.83
SpringWorks Therapeutics, Inc. 5 $126.45
Astellas Pharma US Inc 5 $103.68
Takeda Pharmaceuticals U.S.A., Inc. 5 $99.94
EMD Serono, Inc. 3 $94.64

By nature of payment

Food and Beverage
$4,791
Consulting Fee
$2,745

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
517
Patients
78
Total drug cost
$1,586,329
Drug Type Claims Patients Total cost
Eliquis (Apixaban) Brand 63 17 $46,775
Neulasta Onpro (Pegfilgrastim) Brand 63 17 $427,248
Anastrozole Generic 52 17 $1,547
Levothyroxine Sodium Generic 45 0 $453
Aranesp (Darbepoetin Alfa In Polysorbat) Brand 36 0 $116,337
Exemestane Generic 34 0 $2,165
Lynparza (Olaparib) Brand 33 0 $465,931
Xgeva (Denosumab) Brand 30 0 $95,087
Prednisone Generic 29 13 $190
Xarelto (Rivaroxaban) Brand 26 0 $21,986

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Diana Superfin's medical specialty?
Dr. Diana Superfin practices Hematology & Oncology Physician in Walnut Creek, CA.
Where does Dr. Diana Superfin practice?
Dr. Diana Superfin practices at 500 Lennon Ln, Walnut Creek, CA 945982415. Office phone: 9259399610.
What is Dr. Diana Superfin's NPI?
Dr. Diana Superfin's National Provider Identifier (NPI) is 1750365953, issued by NPPES.
Does Dr. Diana Superfin accept Medicare assignment?
Yes. Dr. Diana Superfin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Diana Superfin commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881). Source: CMS Medicare Physician & Other Practitioners file.